poisar

Stocks · News reference

Silence Therapeutics Reports Third Quarter 2026 Financial Results

Fiscal.ai

Silence Therapeutics announced its third-quarter financial results, reporting a narrowed net loss of $0.08 per share.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading